Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;

Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study C. von Muhlenbrock; G. Landskron; A.M. Madrid;

Current vision on diagnosis and comprehensive care in hepatic encephalopathy F. Higuera-de-la-Tijera; J.A. Velarde-Ruiz Velasco; R.H. Raña-Garibay; G.E. Castro-Narro; J.M. Abdo-Francis; R. Moreno-Alcántar; J.L. Pérez-Hernández; A. Torre; R. Contreras-Omaña; A. Cano-Contreras; M. Castillo-Barradas; J. Pérez-Escobar; J.M. Aldana-Ledesma; E. Cerda-Reyes; N.J. Fernández-Pérez; J. Meza-Cardona; N.C. Flores-García; M. Reyes-Bastidas; J.E. Lira-Vera; E.S. García-Jiménez; D. Santana-Vargas; V.M. Páez-Zayas; N.C. Chávez-Tapia; E. Márquez-Guillén;